Physician profile
Ryan Li
NPI 1790129278
$41,983.07
in general payments reported to CMS, 2019-2025
11 companies · $60.50 in 2025
The $60.50 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2023: $297 · 2024: $162 · 2025: $60.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502 · Education: $16.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.34 |
| Education | $16.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,887.37 | 2019 | |
| Smith+Nephew, INC. | $4,175.98 | 2019 | |
| Arthrex, INC. | $1,092.71 | 2019 | |
| Mid-Atlantic Surgical Systems, LLC | $646.98 | 2019 | |
| Southtech Orthopedics | $555.00 | 2019 | |
| Stryker Corporation | $215.79 | 2019-2024 | Aequalis Flex Revive, Aequalis Ascend Flex |
| Miach Orthopaedics, INC. | $170.93 | 2023 | |
| Next Science LLC | $97.18 | 2023 | Blastx, Xperience, Surgx |
| Tricoast Surgical Solutions LLC | $60.50 | 2025 | |
| Vericel Corporation | $45.65 | 2023-2024 | Maci |
| Depuy Synthes Sales INC. | $34.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.